Compare NetEase Inc (NTES) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NetEase Inc vs Regeneron Pharmaceuticals Inc — how do they compare? NetEase Inc trades at $134.95 (market cap $86.14B), while Regeneron Pharmaceuticals Inc trades at $670 (market cap $70.47B). The key difference: NetEase Inc is the larger of the two by market cap, and NetEase Inc pays the higher dividend (2.25%). Which is the better fit depends on your goals.
| NTES | REGN | |
|---|---|---|
Market Cap | $86.14B | $70.47B |
Sector | Media | Health |
52-Week High | $159.34 | $812.27 |
52-Week Low | $109.26 | $545.46 |
Enterprise Value | $62.61B | $64.42B |
Dividend Yield | 2.25% | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
